Femme et Homme
- | Pays :
- Switzerland
- Belgium
- France
- Les 5 autres...
- | Organes : -
- | Spécialités : -
Extrait
Surinabant is a new, potent and selective antagonist for the cannabinoid CB1 receptor, which might be clinically useful in the treatment of dependence to nicotine. The primary study objective is the assessment of efficacy of 3 doses of surinabant on abstinence from smoking in cigarette smokers. The main secondary objectives are the effect of surinabant on body weight and its clinical and biological safety.
Critère d'inclusion
- SMOKING CESSATION